Literature DB >> 21323809

Closing the loop.

E Dassau1, E Atlas, M Phillip.   

Abstract

Closed-loop algorithms can be found in every aspect of everyday modern life. Automation and control are used constantly to provide safety and to improve quality of life. Closed-loop systems and algorithms can be found in home appliances, automobiles, aviation and more. Can one imagine nowadays driving a car without ABS, cruise control or even anti-sliding control? Similar principles of automation and control can be used in the management of diabetes mellitus (DM). The idea of an algorithmic/technological way to control glycaemia is not new and has been researched for more than four decades. However, recent improvements in both glucose-sensing technology and insulin delivery together with advanced control and systems engineering made this dream of an artificial pancreas possible. The artificial pancreas may be the next big step in the treatment of DM since the use of insulin analogues. An artificial pancreas can be described as internal or external devices that use continuous glucose measurements to automatically manage exogenous insulin delivery with or without other hormones in an attempt to restore glucose regulation in individuals with DM using a control algorithm. This device as described can be internal or external; can use different types of control algorithms with bi-hormonal or uni-hormonal design; and can utilise different ways to administer them. The different designs and implementations have transitioned recently from in silico simulations to clinical evaluation stage with practical applications in mind. This may mark the beginning of a new era in diabetes management with the introduction of semi-closed-loop systems that can prevent or minimise nocturnal hypoglycaemia, to hybrid systems that will manage blood glucose (BG) levels with minimal user intervention to finally fully automated systems that will take the user out of the loop. More and more clinical trials will be needed for the artificial pancreas to become a reality but initial encouraging results are proof that we are on the right track. We attempted to select recent publications that will present these current achievements in the quest for the artificial pancreas and that will inspire others to continue to progress this field of research.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21323809     DOI: 10.1111/j.1742-1241.2010.02575.x

Source DB:  PubMed          Journal:  Int J Clin Pract Suppl        ISSN: 1368-504X


  4 in total

Review 1.  Wearable and implantable pancreas substitutes.

Authors:  Leonardo Ricotti; Tareq Assaf; Paolo Dario; Arianna Menciassi
Journal:  J Artif Organs       Date:  2012-09-20       Impact factor: 1.731

Review 2.  Influences on Technology Use and Efficacy in Type 1 Diabetes.

Authors:  Victoria Franklin
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

3.  Patient perspectives on personalized glucose advisory systems for type 1 diabetes management.

Authors:  Jaclyn A Shepard; Linda Gonder-Frederick; Karen Vajda; Boris Kovatchev
Journal:  Diabetes Technol Ther       Date:  2012-08-02       Impact factor: 6.118

4.  Systematically in silico comparison of unihormonal and bihormonal artificial pancreas systems.

Authors:  Xiaoteng Gao; Huangjiang Ning; Youqing Wang
Journal:  Comput Math Methods Med       Date:  2013-10-24       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.